Icariin Treatment Rescues Diabetes Induced Bone Loss via Scavenging ROS and Activating Primary Cilia/Gli2/Osteocalcin Signaling Pathway

作者全名："Liu, Jie; Cheng, Qingfeng; Wu, Xiangmei; Zhu, Huifang; Deng, Xiaoyan; Wang, Maorong; Yang, Shengyong; Xu, Jie; Chen, Qian; Li, Mengxue; Liu, Xianjun; Wang, Changdong"

作者地址："[Liu, Jie; Zhu, Huifang; Deng, Xiaoyan; Yang, Shengyong; Xu, Jie; Chen, Qian; Li, Mengxue; Liu, Xianjun; Wang, Changdong] Chongqing Med Univ, Coll Basic Med, Mol Med & Canc Res Ctr, Dept Biochem & Mol Biol, Chongqing 400016, Peoples R China; [Cheng, Qingfeng] Chongqing Med Univ, Dept Endocrinol, Affiliated Hosp 1, Chongqing 401331, Peoples R China; [Wu, Xiangmei] Chongqing Med Univ, Coll Basic Med, Mol Med & Canc Res Ctr, Dept Physiol, Chongqing 400016, Peoples R China; [Wang, Maorong] Hubei Univ Nationalities, Dept Endocrinol, Affiliated Hosp, Enshi 445000, Peoples R China"

通信作者："Wang, CD (通讯作者)，Chongqing Med Univ, Coll Basic Med, Mol Med & Canc Res Ctr, Dept Biochem & Mol Biol, Chongqing 400016, Peoples R China."

来源：CELLS

ESI学科分类：BIOLOGY & BIOCHEMISTRY

WOS号：WOS:000900545200001

JCR分区：Q2

影响因子：6

年份：2022

卷号：11

期号：24

开始页：　

结束页：　

文献类型：Article

关键词：diabetes; bone loss; primary cilia; Icariin; ROS

摘要："Diabetes-associated bone complications lead to fragile bone mechanical strength and osteoporosis, aggravating the disease burden of patients. Advanced evidence shows that chronic hyperglycemia and metabolic intermediates, such as inflammatory factor, reactive oxygen species (ROS), and advanced glycation end products (AGEs), are regarded as dominant hazardous factors of bone complications, whereas the pathophysiological mechanisms are complex and controversial. By establishing a diabetic Sprague-Dawley (SD) rat model and diabetic bone loss cell model in vitro, we confirmed that diabetes impaired primary cilia and led to bone loss, while adding Icariin (ICA) could relieve the inhibitions. Mechanistically, ICA could scavenge ROS to maintain the mitochondrial and primary cilia homeostasis of osteoblasts. Intact primary cilia acted as anchoring and modifying sites of Gli2, thereby activating the primary cilia/Gli2/osteocalcin signaling pathway to promote osteoblast differentiation. All results suggest that ICA has potential as a therapeutic drug targeting bone loss induced by diabetes."

基金机构：　

基金资助正文：